Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 133 Pages
Report ld: 3504318
Request Sample
Customized Report
The global market for 3-in-1 Oral CBCT was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Three-in-one oral CBCT refers to the addition of mid-field or small-field CBCT on the basis of a digital panoramic machine, which is a type of CBCT. The core global oral CBCT companies are KaVo Group, Planmeca, Dentsply Sirona, NewTom, Carestream, Vatech and Meyer, among which the share of the top five companies in the Chinese market has reached 60%.
This report aims to provide a comprehensive presentation of the global market for 3-in-1 Oral CBCT, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of 3-in-1 Oral CBCT by region & country, by Type, and by Application.
The 3-in-1 Oral CBCT market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3-in-1 Oral CBCT.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of 3-in-1 Oral CBCT manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of 3-in-1 Oral CBCT in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of 3-in-1 Oral CBCT in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 3-in-1 Oral CBCT Product Introduction
1.2 Global 3-in-1 Oral CBCT Market Size Forecast
1.2.1 Global 3-in-1 Oral CBCT Sales Value (2020-2031)
1.2.2 Global 3-in-1 Oral CBCT Sales Volume (2020-2031)
1.2.3 Global 3-in-1 Oral CBCT Sales Price (2020-2031)
1.3 3-in-1 Oral CBCT Market Trends & Drivers
1.3.1 3-in-1 Oral CBCT Industry Trends
1.3.2 3-in-1 Oral CBCT Market Drivers & Opportunity
1.3.3 3-in-1 Oral CBCT Market Challenges
1.3.4 3-in-1 Oral CBCT Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global 3-in-1 Oral CBCT Players Revenue Ranking (2024)
2.2 Global 3-in-1 Oral CBCT Revenue by Company (2020-2025)
2.3 Global 3-in-1 Oral CBCT Players Sales Volume Ranking (2024)
2.4 Global 3-in-1 Oral CBCT Sales Volume by Company Players (2020-2025)
2.5 Global 3-in-1 Oral CBCT Average Price by Company (2020-2025)
2.6 Key Manufacturers 3-in-1 Oral CBCT Manufacturing Base and Headquarters
2.7 Key Manufacturers 3-in-1 Oral CBCT Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of 3-in-1 Oral CBCT
2.9 3-in-1 Oral CBCT Market Competitive Analysis
2.9.1 3-in-1 Oral CBCT Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by 3-in-1 Oral CBCT Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 3-in-1 Oral CBCT as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Big FOV
3.1.2 Medium and Small FOV
3.2 Global 3-in-1 Oral CBCT Sales Value by Type
3.2.1 Global 3-in-1 Oral CBCT Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global 3-in-1 Oral CBCT Sales Value, by Type (2020-2031)
3.2.3 Global 3-in-1 Oral CBCT Sales Value, by Type (%) (2020-2031)
3.3 Global 3-in-1 Oral CBCT Sales Volume by Type
3.3.1 Global 3-in-1 Oral CBCT Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global 3-in-1 Oral CBCT Sales Volume, by Type (2020-2031)
3.3.3 Global 3-in-1 Oral CBCT Sales Volume, by Type (%) (2020-2031)
3.4 Global 3-in-1 Oral CBCT Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Private Clinic
4.1.2 Hospital
4.2 Global 3-in-1 Oral CBCT Sales Value by Application
4.2.1 Global 3-in-1 Oral CBCT Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global 3-in-1 Oral CBCT Sales Value, by Application (2020-2031)
4.2.3 Global 3-in-1 Oral CBCT Sales Value, by Application (%) (2020-2031)
4.3 Global 3-in-1 Oral CBCT Sales Volume by Application
4.3.1 Global 3-in-1 Oral CBCT Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global 3-in-1 Oral CBCT Sales Volume, by Application (2020-2031)
4.3.3 Global 3-in-1 Oral CBCT Sales Volume, by Application (%) (2020-2031)
4.4 Global 3-in-1 Oral CBCT Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global 3-in-1 Oral CBCT Sales Value by Region
5.1.1 Global 3-in-1 Oral CBCT Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global 3-in-1 Oral CBCT Sales Value by Region (2020-2025)
5.1.3 Global 3-in-1 Oral CBCT Sales Value by Region (2026-2031)
5.1.4 Global 3-in-1 Oral CBCT Sales Value by Region (%), (2020-2031)
5.2 Global 3-in-1 Oral CBCT Sales Volume by Region
5.2.1 Global 3-in-1 Oral CBCT Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global 3-in-1 Oral CBCT Sales Volume by Region (2020-2025)
5.2.3 Global 3-in-1 Oral CBCT Sales Volume by Region (2026-2031)
5.2.4 Global 3-in-1 Oral CBCT Sales Volume by Region (%), (2020-2031)
5.3 Global 3-in-1 Oral CBCT Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America 3-in-1 Oral CBCT Sales Value, 2020-2031
5.4.2 North America 3-in-1 Oral CBCT Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe 3-in-1 Oral CBCT Sales Value, 2020-2031
5.5.2 Europe 3-in-1 Oral CBCT Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific 3-in-1 Oral CBCT Sales Value, 2020-2031
5.6.2 Asia Pacific 3-in-1 Oral CBCT Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America 3-in-1 Oral CBCT Sales Value, 2020-2031
5.7.2 South America 3-in-1 Oral CBCT Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa 3-in-1 Oral CBCT Sales Value, 2020-2031
5.8.2 Middle East & Africa 3-in-1 Oral CBCT Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions 3-in-1 Oral CBCT Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions 3-in-1 Oral CBCT Sales Value
6.2.1 Key Countries/Regions 3-in-1 Oral CBCT Sales Value, 2020-2031
6.2.2 Key Countries/Regions 3-in-1 Oral CBCT Sales Volume, 2020-2031
6.3 United States
6.3.1 United States 3-in-1 Oral CBCT Sales Value, 2020-2031
6.3.2 United States 3-in-1 Oral CBCT Sales Value by Type (%), 2024 VS 2031
6.3.3 United States 3-in-1 Oral CBCT Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe 3-in-1 Oral CBCT Sales Value, 2020-2031
6.4.2 Europe 3-in-1 Oral CBCT Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe 3-in-1 Oral CBCT Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China 3-in-1 Oral CBCT Sales Value, 2020-2031
6.5.2 China 3-in-1 Oral CBCT Sales Value by Type (%), 2024 VS 2031
6.5.3 China 3-in-1 Oral CBCT Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan 3-in-1 Oral CBCT Sales Value, 2020-2031
6.6.2 Japan 3-in-1 Oral CBCT Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan 3-in-1 Oral CBCT Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea 3-in-1 Oral CBCT Sales Value, 2020-2031
6.7.2 South Korea 3-in-1 Oral CBCT Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea 3-in-1 Oral CBCT Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia 3-in-1 Oral CBCT Sales Value, 2020-2031
6.8.2 Southeast Asia 3-in-1 Oral CBCT Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia 3-in-1 Oral CBCT Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India 3-in-1 Oral CBCT Sales Value, 2020-2031
6.9.2 India 3-in-1 Oral CBCT Sales Value by Type (%), 2024 VS 2031
6.9.3 India 3-in-1 Oral CBCT Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Vatech
7.1.1 Vatech Company Information
7.1.2 Vatech Introduction and Business Overview
7.1.3 Vatech 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Vatech 3-in-1 Oral CBCT Product Offerings
7.1.5 Vatech Recent Development
7.2 Pointnix
7.2.1 Pointnix Company Information
7.2.2 Pointnix Introduction and Business Overview
7.2.3 Pointnix 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Pointnix 3-in-1 Oral CBCT Product Offerings
7.2.5 Pointnix Recent Development
7.3 Planmeca
7.3.1 Planmeca Company Information
7.3.2 Planmeca Introduction and Business Overview
7.3.3 Planmeca 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Planmeca 3-in-1 Oral CBCT Product Offerings
7.3.5 Planmeca Recent Development
7.4 Instrumentarium
7.4.1 Instrumentarium Company Information
7.4.2 Instrumentarium Introduction and Business Overview
7.4.3 Instrumentarium 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Instrumentarium 3-in-1 Oral CBCT Product Offerings
7.4.5 Instrumentarium Recent Development
7.5 Genoray
7.5.1 Genoray Company Information
7.5.2 Genoray Introduction and Business Overview
7.5.3 Genoray 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Genoray 3-in-1 Oral CBCT Product Offerings
7.5.5 Genoray Recent Development
7.6 DEXIS
7.6.1 DEXIS Company Information
7.6.2 DEXIS Introduction and Business Overview
7.6.3 DEXIS 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 DEXIS 3-in-1 Oral CBCT Product Offerings
7.6.5 DEXIS Recent Development
7.7 FUSSEN
7.7.1 FUSSEN Company Information
7.7.2 FUSSEN Introduction and Business Overview
7.7.3 FUSSEN 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 FUSSEN 3-in-1 Oral CBCT Product Offerings
7.7.5 FUSSEN Recent Development
7.8 Ray Co., Ltd
7.8.1 Ray Co., Ltd Company Information
7.8.2 Ray Co., Ltd Introduction and Business Overview
7.8.3 Ray Co., Ltd 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Ray Co., Ltd 3-in-1 Oral CBCT Product Offerings
7.8.5 Ray Co., Ltd Recent Development
7.9 NewTom
7.9.1 NewTom Company Information
7.9.2 NewTom Introduction and Business Overview
7.9.3 NewTom 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 NewTom 3-in-1 Oral CBCT Product Offerings
7.9.5 NewTom Recent Development
7.10 KaVo Dental
7.10.1 KaVo Dental Company Information
7.10.2 KaVo Dental Introduction and Business Overview
7.10.3 KaVo Dental 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 KaVo Dental 3-in-1 Oral CBCT Product Offerings
7.10.5 KaVo Dental Recent Development
7.11 Beijing Largev
7.11.1 Beijing Largev Company Information
7.11.2 Beijing Largev Introduction and Business Overview
7.11.3 Beijing Largev 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Beijing Largev 3-in-1 Oral CBCT Product Offerings
7.11.5 Beijing Largev Recent Development
7.12 Shanghai Bondent
7.12.1 Shanghai Bondent Company Information
7.12.2 Shanghai Bondent Introduction and Business Overview
7.12.3 Shanghai Bondent 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Shanghai Bondent 3-in-1 Oral CBCT Product Offerings
7.12.5 Shanghai Bondent Recent Development
7.13 Guangzhou Huaduantech
7.13.1 Guangzhou Huaduantech Company Information
7.13.2 Guangzhou Huaduantech Introduction and Business Overview
7.13.3 Guangzhou Huaduantech 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Guangzhou Huaduantech 3-in-1 Oral CBCT Product Offerings
7.13.5 Guangzhou Huaduantech Recent Development
7.14 Shenzhen Angell
7.14.1 Shenzhen Angell Company Information
7.14.2 Shenzhen Angell Introduction and Business Overview
7.14.3 Shenzhen Angell 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Shenzhen Angell 3-in-1 Oral CBCT Product Offerings
7.14.5 Shenzhen Angell Recent Development
7.15 Hefei Meyer
7.15.1 Hefei Meyer Company Information
7.15.2 Hefei Meyer Introduction and Business Overview
7.15.3 Hefei Meyer 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Hefei Meyer 3-in-1 Oral CBCT Product Offerings
7.15.5 Hefei Meyer Recent Development
7.16 Carestream Health
7.16.1 Carestream Health Company Information
7.16.2 Carestream Health Introduction and Business Overview
7.16.3 Carestream Health 3-in-1 Oral CBCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Carestream Health 3-in-1 Oral CBCT Product Offerings
7.16.5 Carestream Health Recent Development
8 Industry Chain Analysis
8.1 3-in-1 Oral CBCT Industrial Chain
8.2 3-in-1 Oral CBCT Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 3-in-1 Oral CBCT Sales Model
8.5.2 Sales Channel
8.5.3 3-in-1 Oral CBCT Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for 3-in-1 Oral CBCT was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 153
USD 3950.00
(Single User License)
The global 3-in-1 Oral CBCT market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 136
USD 2900.00
(Single User License)
The global 3-in-1 Oral CBCT market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 104
USD 4250.00
(Single User License)
The global 3-in-1 Oral CBCT market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 176
USD 4900.00
(Single User License)
The global market for 3-in-1 Oral CBCT was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 102
USD 2900.00
(Single User License)
The global 3-in-1 Oral CBCT market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-15
Pages: 113
USD 4900.00
(Single User License)
The global 3-in-1 Oral CBCT market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-18
Pages: 103
USD 2900.00
(Single User License)
The global market for 3-in-1 Oral CBCT was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 153
The global 3-in-1 Oral CBCT market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 136
The global 3-in-1 Oral CBCT market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 104
The global 3-in-1 Oral CBCT market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 176
The global market for 3-in-1 Oral CBCT was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 102
The global 3-in-1 Oral CBCT market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-15
Pages: 113
The global 3-in-1 Oral CBCT market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 103
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now